Digene Corp.

Company announces settlement, license agreement with Georgetown

Published in Medical Patent Law Weekly, August 10th, 2005

Digene Corp. (DIGE) announced that the company has entered into a settlement and license agreement with Georgetown University to settle its litigation, currently pending in the United States District Court for the District of Columbia.

The litigation between the company and Georgetown University began in October, 2004, and relates to a license agreement with Georgetown University for U.S. patent no. 5,643,715 and corresponding foreign patents and patent applications relating to human papillomavirus (HPV) type 52, and to U.S. patent no. 5,057,411 and corresponding foreign patents relating to the use of the L1 gene sequence to detect specific HPV types.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly

Source: Medical Patent Law Weekly (2005-08-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry